PMC:7195088 / 44088-44201
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1207 | 41-49 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T74 | 2-10 | Body_part | denotes | Antibody | http://purl.org/sig/ont/fma/fma62871 |
| T75 | 72-80 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T347 | 0-113 | Sentence | denotes | • Antibody development (up to 50% of the patients but no correlation of antibody development and adverse effects) |